Paloma Partners’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Paloma Partners’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-578	Closed	-$38K	–	2488
2021 Q1	$38K	Buy	+578	New	+$40.3K	﹤0.01%	1966
2017 Q3	–	Sell	-350	Closed	-$61K	–	2565
2017 Q2	$61K	Buy	+350	New	+$49.8K	﹤0.01%	2102
2015 Q1	–	Sell	-389	Closed	-$61K	–	1495
2014 Q4	$61K	Sell	389 -41	-10%	-$5.91K	﹤0.01%	1090
2014 Q3	$62K	Buy	+430	New	+$62.3K	﹤0.01%	936

Other funds holding SRGA

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Paloma Partners's SRGA Position: Q2 2021 in Review

Paloma Partners sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 578 shares — an estimated $38K sold.

Paloma Partners first reported a position in SRGA in Q3 2014 and held it in 4 quarters. The position peaked at $62K in Q3 2014. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

Paloma Partners reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Paloma Partners sold 578 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $38K.
Paloma Partners first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2014 and held it in 4 quarters.
Paloma Partners's Surgalign Holdings, Inc. Common Stock position peaked at $62K in Q3 2014.
89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.